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The presence of ATP within cells is well established.
However, ATP also operates as an intercellular signal
via specific purinoceptors. Furthermore, nonsecretory
cells can release ATP under certain experimental con-
ditions. To measure ATP release and membrane cur-
rents from a single cell simultaneously, we used Xenopus
oocytes. We simultaneously recorded membrane cur-
rents and luminescence. Here, we show that ATP release
can be triggered in Xenopus oocytes by hyperpolarizing
pulses. ATP release (3.2 6 0.3 pmol/oocyte) generated a
slow inward current (2.3 6 0.1 mA). During hyperpolar-
izing pulses, the permeability for ATP4– was more than
4000 times higher than that for Cl–. The sensitivity to
GdCl3 (0.2 mM) of hyperpolarization-induced ionic cur-
rent, ATP release and E-ATPase activity suggests their
dependence on stretch-activated ion channels. The
pharmacological profile of the current inhibition coin-
cides with the inhibition of ecto-ATPase activity. This
enzyme is highly conserved among species, and in hu-
mans, it has been cloned and characterized as CD39. The
translation, in Xenopus oocytes, of human CD39 mRNA
encoding enhances the ATP-supported current, indicat-
ing that CD39 is directly or indirectly responsible for
the electrodiffusion of ATP.
Eukaryotic cells constantly form ATP, which has a large
variety of functions. In addition, exocytosis of a variety of
granules or vesicles results in ATP release, such as in the
neuromuscular junction (1), in rat cerebral cortex synapto-
somes (2), in celiac neurons (3), in isolated cholinergic nerve
terminals from Torpedo electric organ (4), and chromaffin cells
(5). Nonsecretory cells can also release ATP, as in skeletal
muscle (6), heart cells (7), erythrocytes (8), Torpedo electric
organ (9), astrocytes (10), smooth muscle (11), and airway
epithelium (12). Because cells of this type contain few secretory
granules or secretory vesicle-like structures, it has also been
suggested that ATP may not be released through a membrane
fusion pathway.
Indirect evidence has been obtained in support of the hypoth-
esis of nonsecretory exocytotic release of ATP. In patch clamp
experiments (13–15), it was found that cell membranes con-
taining cystic fibrosis transmembrane regulator (CFTR)1 or
related proteins may be permeable to ATP. Direct measure-
ment of ATP release by myosin functionalized tips of atomic
force microscope reveals hot spots of ATP release on the surface
of epithelial cells expressing CFTR (16). Other experimental
reports (12, 17–20) do not support this view, suggesting that
the diameter of the pore of CFTR is too small to allow ATP to
cross the plasma membrane. However, in this type of experi-
ment, it is impossible to measure ATP release and ionic cur-
rents simultaneously in an individual cell, and so it was im-
possible to establish a direct relationship between the current
activation and the release of ATP.
We have developed a simple method to detect ATP release in
oocytes subjected to a two-electrode voltage-clamp (Fig. 1A).
We monitored, on line and simultaneously, the release of ATP
and the currents flowing across the plasma membrane in a
single cell.
EXPERIMENTAL PROCEDURES
Simultaneous Voltage-Clamp Recording and ATP Release—Proce-
dures for preparation of Xenopus laevis oocytes and voltage-clamp re-
cording were as described (21). ATP detection was performed at least
48 h after defolliculation. Oocytes were placed in a dark chamber at
20 °C and bathed in a recording solution containing 115 mM NaCl, 2 mM
KCl, 1.8 mM CaCl2, and 5 mM HEPES/NaOH, pH 7.4. A vial of firefly
lantern luciferase extract from Photinus pyralis (Sigma) was diluted in
2 ml of the recording solution containing 5 mg/ml D-luciferin (Sigma).
The resulting suspension was centrifuged for 30 s in a benchtop centri-
fuge. The supernatant was desalted in a 10-ml 10DG Bio-Rad column
equilibrated with recording solution containing 1.8 mM MgCl2. The
eluate was maintained at 4 °C and placed in the 250-ml recording
chamber. A plastic optic fiber of 1 mm diameter was placed above the
upper surface of an oocyte bathed in a luciferin-luciferase enriched
solution, between the two recording electrodes, and the other end of the
fiber was placed in front of a photomultiplier (Hamamatsu, R374). The
resulting electric signal was filtered at 5 Hz in a Bessel filter (Frequen-
cy Devices) and collected by the Digidata-1200A converter (Axon In-
struments). In some cases, a known dose of ATP was added through a
third pipette, with a calibrated volume ejected by pressure (PLI-100,
Medical Systems). In some experiments, six optic fibers were placed in
front of the six planes of the recording cuvette.
Characterization of Ionic Currents—In some experiments, Xenopus
oocyte plasma membrane capacitance was measured before and after
applying a hyperpolarizing pulse from –60 to –180 mV. Cell membrane
electrical capacitance was calculated by recording the capacitative tran-
sient associated with a small voltage step (from –60 to –90 mV), during
* This work was supported by Dirección General de Enseñanza Su-
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which the inward current was not activated. Integration of the tran-
sient yielded the charge (Q) transferred during the voltage step (V),
from which capacitance (C) was calculated as follows: C 5 Q/V.
The reversal potential was calculated while the current was still
flowing. 100-ms pulses ranging from –220 to –150 mV, in 10-mV jumps,
were imposed in the last 2 s of 20-s hyperpolarizing pulses. The currents
were plotted against voltage, and extrapolation to zero was calculated.
The reversal potential of the residual current, calculated at different
potentials at the end of the 10-s hyperpolarizing pulse, was –22 6 3 mV
(n 5 10), ranging from –15 to –23 mV.
Permeability of the membrane to ATP4– was calculated according to
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(Eq. 1)
where F is Faraday’s constant, R is the gas constant, T is the absolute
temperature in Kelvin, Z is the valence of ATP or chloride, and E is the
reversal potential. Internal Cl2 concentration was 62 mM, according to
Dascal (50).
The number of ATP molecules (n) that crossed the oocyte plasma
membrane was calculated as follows: n 5 *I(dt)/(e–zuZu), where *I(dt) is
the electrical charge (in coulombs) that crossed the plasma membrane,
thus generating the elicited current (I), e– is the electrical charge of one
electron (in coulombs) and uZu is the valence. The leak current was
subtracted, and the charge was calculated as the area delimited by the
current.
ATP Content of Xenopus Oocytes—ATP content was measured in
groups of 10 oocytes, which were homogenized in the presence of tri-
chloroacetic acid 5%, left to stand for 30 min at 4 °C and finally centri-
fuged in a benchtop centrifuge for 5 min. Trichloroacetic acid from the
supernatant was removed by washing the suspension in ethyl-ether
until the pH of the aqueous phase was above 4.5. The amount of ATP
was determined by the luciferin-luciferase luminescent reaction.
Ecto-ATPase Activity—Ecto-ATPase (E-type ATPase) activity of de-
folliculated Xenopus oocytes was assayed according to (22), in groups of
10 oocytes incubated in a saline solution containing ATP (1 mM). To
activate ATPase, CaCl2 (1 mM) was added.
Expression of Human CD39 in Xenopus Oocytes—Total RNA was
isolated from human B-lymphocytes using the UltraspecTM RNA isola-
tion system (Biotecx). A sample of 2.7 mg of total RNA served as
template for cDNA synthesis by reverse transcriptase (MuLV, Perkin-
Elmer). The sense primer (59-TCCCCCGGGCTTATGGAAGATA-
CAAAGGAGTCTAAC-39) contained a sequence identical to nucleotides
65–91 of human CD39. The antisense primer (59-TCCCCCGGGCTAT-
ACCATATCTTTCCAGAAATATGA-39) was complementary to nucleo-
tides 1574–1600 of the CD39 coding sequence. After amplification, the
PCR product (1530 bp) was subcloned into pCR2.1 plasmid (Invitrogen)
and sequenced with the DNA sequencing kit (PE Bio systems). This
construct (10 mg) was linearized with BamHI (Promega), and the re-
sultant product was used for in vitro mRNA synthesis using the
mCAPTM RNA capping kit (Stratagene). The mRNA obtained was in-
jected (1–2 mg/ml) into oocytes 3 days before starting current recording.
RESULTS AND DISCUSSION
In defolliculated Xenopus oocytes, hyperpolarizing square
pulses (Fig. 1B) generated a slow inward current of varying
amplitude (2.3 6 0.1 mA; t 5 1.8 6 0.6 s; n 5 191), depending
on the oocyte batch. ATP release during the generation of this
current, measured in 40 oocytes, was 3.2 6 0.3 pmol of ATP/
oocyte, in pulses from –60 to –200 mV. The amount of ATP
released was proportional to the amplitude of the hyperpolar-
izing pulse. The pulses from –60 to –180 mV gave a signifi-
cantly (p , 0.001) lower ATP peak (54 6 9%; n 5 10) and a
significantly (p , 0.001) lower inward current (54 6 8%; n 5
12) than pulses from –60 to –200 mV. There were no significant
differences between these values. Sometimes, for a few minutes
after the end of the hyperpolarizing pulse, a small residual
current continued.
We ruled out the exocytotic origin of ATP release from cor-
tical granules (23) of oocytes because it was independent of the
external calcium concentration (2.4 6 0.2 pmol of ATP in the
presence of 1.8 mM CaCl2 and 2.6 6 0.3 pmol in solutions to
which CaCl2 was not added; n 5 4). Cortical granules fuse with
the plasma membrane during fertilization, the oocyte mem-
brane becomes depolarized and calcium enters through volt-
age-sensitive channels. The hyperpolarizing pulses did not
open the voltage-dependent calcium channels at the range used
in these experiments. Furthermore, the membrane capacitance
of the oocytes (24) did not change significantly (203 6 8 nano-
farads before and 194 6 7 nanofarads after applying the hy-
perpolarizing pulse; n 5 8). However, the increase in capaci-
tance due to the fusion of granules may have been below the
sensitivity of the recording techniques (between 10–15 nano-
farads). If we assume that ATP release is supported by the
exocytosis of small granules with a diameter of 100 nm con-
FIG. 1. Voltage-dependent release of ATP from defolliculated
Xenopus oocytes. A, for simultaneous recording of ATP release and
plasma membrane currents, we connected an optic fiber to a conven-
tional two-electrode voltage-clamp set up for Xenopus oocytes. In a dark
chamber, the oocyte was placed in a recording cuvette containing a
luciferin-luciferase mixture. ATP released from the oocytes excited light
emission by the chemiluminescent enzymes. Emitted photons were
captured by the optic fiber, which was connected to a photomultiplier.
o.f., optic fiber; me1 and me2, microelectrodes 1 and 2; E, voltage-clamp
amplifier; Vm, resting membrane potential of oocyte; phmtpl, photomul-
tiplier. B, B.1, hyperpolarizing pulses of 10 s, from –60 to –200 mV, in
–20-mV steps, were applied to an oocyte; holding potential, –60 mV.
B.2, currents elicited by the hyperpolarizing pulses were clearly re-
corded after applying voltages below –160 mV. When membrane poten-
tial returned to –60 mV, the currents disappeared very slowly. Cur-
rents presented in the figure were not corrected for leak. B.3, in voltages
at which an inward current was generated, ATP release was clearly
revealed by the emission of light from the mixture of luciferin-lucifer-
ase. Light was measured in arbitrary units (a.u.).
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taining 100–200 mM ATP, such as synaptic vesicles, which are
also present in the oocyte, it would induce an increase of 50–90
nanofarads, which would release 2–3 pmol of ATP. Such an
increase would be detectable by the recording methods used.
We conclude, therefore, that ATP release is not directly related
to the exocytosis of secretory granules from the oocyte cyto-
plasm. However, we cannot rule out the possibility that a few
membranous structures, such as secretory granules or caveo-
lae, may be incorporated into the oocyte plasmalemma. These
structures could contain a high density of a membrane protein
that transport ATP out of the cell. This mechanism of incorpo-
ration of ion channels to the cell plasma membrane has been
suggested for CFTR (25).
We also examined the ionic permeability associated with the
slow inward current previously described in Xenopus (26, 27)
and in Rana perezi (28) oocytes. Both groups concluded that the
current was not generated by microruptures of the plasma
membrane, which should cause an entry of Na1. The inward
current was still present when external NaCl was replaced by
N-methyl-D-glucamine-Cl (26). We replaced 83% of external
NaCl (15 mM) with urea (200 mM), and the current did not
change significantly (–903 6 33 nA in oocytes bathed in urea-
containing medium, –833 6 23 nA in oocytes bathed in phys-
iological solution; n 5 4). We ruled out the participation of K1
in this current, considering that substitution of Na1 by K1 in
the recording solution did not change the amplitude of the
current (–1767 6 80 nA in oocytes recorded in Na1 substituted
medium; –1835 6 53 nA in oocytes bathed in physiological
solution; n 5 5). In addition, tetraethylammonium (10 mM) did
not change the amplitude of the current (1.5 6 0.1 mA in 10 mM
tetraethylammonium-treated oocytes, 1.5 6 0.6 mA in physio-
logical solution; n 5 8), nor was this current sustained by Cl2;
the substitution of Cl2 by other anions did not change the
amplitude of the inward current, (2.1 6 0.3 mA (n 5 5) for
sodium gluconate; 2.3 6 0.3 mA (n 5 5) for sodium thiocyanate;
1.9 6 0.5 mA for SO4
2–). The blocking drug of voltage-dependent
chloride channels (anthracene-9-carboxylic acid) did not
change the amplitude of the inward current (1.8 6 0.1 mA in
both anthracene-9-carboxylic acid-treated oocytes and oocytes
bathed with physiological solution; n 5 4).
Alternatively, it has been suggested that ATP can cross the
plasma membrane through a hydrophobic channel, although
the results are controversial (12–15, 17–20). The reversal po-
tential varied considerably from one oocyte batch to another,
ranging from 17 to 124 mV, with a mean of 101 6 19 mV (n 5
10). According to the Nernst equation, this reversal potential is
in the range of the equilibrium potential for ATP4–. Ionic ATP
crossing the plasma membrane may have generated this cur-
rent. This was supported by the finding that, using the Gold-
man-Hodgkin and Katz equation, the calculated permeability
of ATP4– was 4531 times higher than that of Cl2 (in the
residual current ATP4– is 4.5 times more permeable than Cl2).
In addition, the number of ATP molecules detected by the
luciferin-luciferase reaction was of the same order of magni-
tude as the number calculated (see under “Experimental Pro-
cedures”) from the current (Fig. 2).
The dependence of intracellular and extracellular ATP con-
centrations on ATP flux was also assayed. Xenopus oocytes
contained 180 6 30 pmol ATP per oocyte; n 5 7. However, we
were unable to determine what proportion of this ATP was
present in the free form in the cytosol, ready to be released or
entrapped into granules or vesicles, and what proportion was
bound to proteins. Divalent cations (Ca21 and Mg21) and pH
determine the ionic derivatives that can be formed from the
ATP molecule. The intracellular calcium concentration of Xe-
nopus oocytes has been estimated to be 35 nM (29); in this range
of Ca21 concentration and at pH 7.4, the ATP inside the cell
must be in the form of ATP4–. The extracellular level of ATP
per oocyte was 404 6 55 fmol/ml (n 5 3). Nevertheless, the
intracellular and extracellular concentrations of ATP fluctuate
because of the activation of intracellular ATPases and extra-
cellular ATP degradation by ectonucleotidases.
Decreasing the ATP content with cyanide treatment induced
both the inhibition of ATP release and a decrease in the charge
FIG. 2. Release of ATP from defolliculated Xenopus oocytes. A,
to estimate the amount of ATP released during a hyperpolarizing pulse,
we added a known dose of ATP near to the oocyte bathed in the
luminescent mixture. A1, voltage command; A2, current trace; A3, light
emitted by ATP release. A known quantity of an ATP solution was
ejected to estimate the amount of ATP released by a single oocyte. B,
comparison of the number of ATP molecules detected by the chemilu-
minescent reaction of luciferin-luciferase and the calculated number of
molecules of ATP with four negative charges that can cross the plasma
membrane and thus produce the current elicited by hyperpolarizing
pulses. The number of chemiluminescently detected molecules fits with
the calculated number of molecules of ATP4– flowing through the
plasma membrane. This figure also illustrates the variability of ATP
release and currents in different oocytes. C, relationship between the
number of molecules of ATP detected by the luciferin-luciferase reaction
and the calculated number of ATP4– molecules crossing the plasma
membrane. Black squares and continuous straight line correspond to
oocytes hyperpolarized from –60 to –200 mV. White circles and discon-
tinuous straight line correspond to oocytes hyperpolarized from –60 to
–180 mV.
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carried by the inward current elicited by hyperpolarizing
pulses (Fig. 3). When ATP (10 mM) was added to the extracel-
lular solution, the inward current increased when negative
potentials were applied (Fig. 4, A and B). This effect might be
related to an endogenous type P2x purinoceptor, but Xenopus
FIG. 3. Effect of cyanide on ATP release from oocytes induced
by hyperpolarization. A, recording from an oocyte. A1, hyperpolariz-
ing voltage command; A2, current (leak current was not subtracted);
A3, light emitted by ATP release. B, recording from the same oocyte
treated with 1 mM NaCN for 10 min. B1, voltage command; B2, current;
B3, light emitted by ATP release. Note that a known dose of ATP was
added before and after perfusing with NaCN, which indicates that the
decrease in light emission was due to a reduction of ATP release rather
than interference in the luminescent reaction. C, plot of results from
five oocytes. C1, effect of 1 mM NaCN on the charge mobilized by the
evoked current; C2, effect of 1 mM NaCN on the hyperpolarization-
induced release of ATP; C3, changes in oocyte ATP content. Bars rep-
resent mean 6 S.E. White bars correspond to nontreated oocytes. CN2
indicates oocytes treated with 1 mM NaCN. ***, p , 0.001.
FIG. 4. Current enhancement by extracellular ATP and by ex-
pression of human CD39. A, effect of the extracellular ATP (10 mM)
on the hyperpolarizing-elicited inward current. A1, hyperpolarizing
voltage command; A2, current (10 mM extracellular ATP increased the
hyperpolarization-elicited current). Leak current was not subtracted. B,
plot of currents elicited by 10-s voltage pulses, in the absence (open
circles) and presence (filled circles) of 10 mM ATP. In hyperpolarizing
pulses, the presence of ATP in the recording medium increased the
voltage-dependent currents. Each data point represents mean 6 S.E.
(n 5 5). C, inward current elicited by hyperpolarizing pulses in water-
injected oocytes (open bar) and in oocytes injected with mRNA for
human CD39 (CD39-labeled bar). Each bar represents mean 6 S.E.
from 47 oocytes injected with water and 39 oocytes injected with mRNA
of human CD39, from three different Xenopus donors .**, p , 0.01.
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oocytes are completely devoid of P2x purinoceptors 48 h after
defolliculation (30). In our experimental conditions with 48–72
h defolliculated oocytes, clamped at –60 mV, ATP (10 mM) did
not, as expected, evoke any current in the presence of P2x
purinoceptors (data not shown). The ectonucleotidase described
in Xenopus oocytes (22) belongs to the group of E-type ATPases
(ecto-ATPase or ecto-apyrase). These are structurally related to
the CD39 lymphocyte antigen, which has recently been cloned
(31). ATPases usually need Mg21 as a cofactor, whereas E-type
ATPases can hydrolyze ATP or ADP using either Ca21 or Mg21
as cofactor. The amount of ATP released from an oocyte under
hyperpolarization pulses did not change when soluble apyrase
(from potato) was added to the recording medium (data not
shown). The hyperpolarization may have blocked the E-ATPase
activity and enhanced the light signal by preventing ATP deg-
radation. Indeed, it has been demonstrated that soluble lucif-
erase does not pick up a transient phase of ATP release from
platelets (32), except when luciferase was placed on the surface
of activated platelets through a chimeric antibody-containing
luciferase.
To test the role of E-ATPase in the current, the enzymatic
activity and ATP release (Table I) we used a blocker of potas-
sium channels, blockers of chloride channels of Xenopus oocytes
and inhibitors of E-ATPase activity. Unfortunately, no specific
inhibitors of this enzymatic activity are available. Suramin, an
antimalarial agent with a Ki in the micromolar range for E-
ATPase activity (33), abolishes either the slow inward current
or the E-ATPase activity of Xenopus oocytes. Table I summa-
rizes the relationship between the generation of the slow in-
ward current and the E-ATPase activity. The degradation of
ATP by E-ATPase (34 6 2 pmol of Pi min
21 oocyte21; n 5 13)
was similar to that previously described (22). The E-ATPase
activity and the inward current were insensitive to Cl2 and K1
channel blockers, but they were both inhibited by suramin.
Zn21 and a high concentration of Ca21 also inhibited the E-AT-
Pase activity and the induced hyperpolarizing inward current.
DIDS and SITS (1 mM), which are commonly used as Cl2
blockers, also inhibited the E-ATPase activity and the elicited
current. The inhibition induced by DIDS (1 mM) was reversible,
whereas that induced by SITS was irreversible. A lower con-
centration of DIDS (0.1 mM) partially inhibited the luciferin-
luciferase reaction, in a such a way that it was possible to
detect ATP release from stimulated oocytes. DIDS (0.1 mM)
inhibited the current, the E-ATPase activity, and ATP release
by the same order of magnitude (Table I). In addition, the lack
of action of glibenclamide indicates that the protein that sup-
ports ATP release is not of the ABC type. In summary, the
inhibition of E-ATPase always correlated with the inhibition of
the inward current. However, it has recently been reported
that Gd31 (200 mM) inhibits ATP release from rat hepatoma
cells (34). In those experiments, ATP release was induced by
hypotonic solution, suggesting that it is sensitive to cell volume
changes. It has also been demonstrated that gadolinium blocks
stretch-activated ion channels (35). We show (Table I) that
solutions containing Gd31 (200 mM) inhibited the hyperpolar-
ization-induced current, E-ATPase, and ATP release. Again,
there is an association between current, E-ATPase activity and
ATP release. We suggest that ATP release from oocytes can be
triggered by the activation of stretch-sensitive ion channels,
which in turn may be directly associated to E-ATPases. Indeed,
mechanically gated channels are present in Xenopus oocytes
(27).
Translation of the mRNA of human CD39 enhanced the
inward current (Fig. 4C), thus demonstrating a direct relation-
ship between E-type ATPase and the inward current. In 26
oocytes injected with a truncated form (nucleotides 640–750),
the current was not enhanced. Indeed, it has been suggested
(36) that E-type ATPases such as CD39 might be able to form
membrane channels. The antigen CD39, like P2x receptors and
inwardly rectifying potassium channels, is an integral mem-
brane protein, with two transmembrane domains and a large
extracellular region that become active when tetramers are
formed (36). This protein may participate in two apparently
contradictory functions: the release of ATP and its degradation.
However, two different activity states have been suggested (37)
for E-ATPases, both of which can account for our results: the
E-type molecule acts as an ionic channel or a membrane trans-
porter of ATP in response to hydrolysis or binding of ATP. The
E-type ATPases may, in resting conditions, be involved in some
kind of transport process, by consuming extracellular ATP; the
voltage or stretch stimulus would change the protein confor-
mation, inducing ATP transport out of the cell. In physiological
conditions, cells do not reach the low levels of voltage fixed in
our experiments. The physiological stimulus for ATP release
may be stretching.
Different cells, such as muscle fibers, neurons, or lining
epithelial cells secrete ATP (see the Introduction). ATP release
from epithelial cells may be relevant to genetic diseases. Cystic
TABLE I
Relationship between activation current, ecto-ATPase activity, and ATP release
Currents were evoked by hyperpolarizing pulses from 260 to 2200 mV, before and after perfusing the oocyte with the test solutions. The
inhibition of these agents was reversible after 15 min of washing, except in the case of SIDS, for which the inhibition was irreversible. The
E-ATPase activity was determined in groups of 10 defolliculated oocytes. Most of the agents that inhibited E-type ATPase activity also inhibited
the luminescent reaction of luciferin-luciferase: a known dose of ATP was applied to the bath, and no response was recorded. The inward current
was inhibited in oocytes treated with SIDS and extensively washed. In these treated oocytes, we measured ATP release without any interference
of SIDS with chemiluminescent enzymes; in this case, oocytes were not able to release ATP under hyperpolarising conditions. i.r., this condition
interferes with the reaction.
Condition Current inhibition E-ATPase activityinhibition
ATP release inhibition
(n 5 4)
% n % n
Anthracene-9-carboxylic acid, 2 mM 3 6 3 4 4 6 2 4 i.r.
Tetraethylammonium, 10 mM 2 6 7 8 11 6 4 4 0
Glibenclamide, 1 mM 5 6 1 2 11 6 4 4 0
CaCl2, 12 mM 34 6 7
a 5 60 6 6b 4 i.r.
Suramin, 50 mM 51 6 6b 3 52 6 4a 4 i.r.
SITS, 1 mM 67 6 7a 5 95 6 2b 4 100
DIDS, 1 mM 87 6 7a 2 93 6 2b 4 i.r.
DIDS, 0.1 mM 63 6 1c 4 61 6 4b 3 70 6 1c
GdCl3, 0.2 mM 76 6 3
b 4 100 6 0a 3 74 6 7c
ZnCl2, 5 mM 86 6 6
a 5 100 6 6a 4 i.r.
a p , 0.001.
b p , 0.01.
c p , 0.05.
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fibrosis is a genetic disease caused by amino acid mutations in
the sequence of the CFTR protein. CFTR is a membrane pro-
tein that is permeant for chloride anions (18, 38–41) and is
located in the apical plasma membrane of the airway epithe-
lium and other epithelial cells. The reduction of the chloride
secretion in the respiratory pathways may explain the patho-
physiology of cystic fibrosis patients (42). It has been suggested
that in addition to its contribution to Cl2 cell permeability,
CFTR can also support ATP permeability (15, 43–46). Airway
epithelium releases ATP under mechanical stress (12) or under
hyposmotic stress (47) in which cystic fibrosis patients epithe-
lia fail to release ATP. Three cell mechanisms have been sug-
gested to explain this ATP release (25). The first possibility is
that CFTR may support ATP release directly, and it should
therefore permeate either chloride or ATP ions. The second
possibility is that ATP can be released through a different kind
of protein or ionic channel, which should, in turn, be activated
by CFTR. The third possibility is that cells incorporate the
ATP-releasing protein by the exocytosis of granules of it in
their membrane; CFTR would then be implicated in the regu-
lation of exocytosis. Our results support the second possibility,
according to which CD39 would be directly involved in ATP
release, whereas CFTR would play a modulatory role. A recent
report (48), measuring the release of ATP from single oocytes,
pointed out that oocytes from some specific female donors ex-
pressing CFTR released ATP under certain restricted condi-
tions, such as the presence of cAMP and changes in extracel-
lular chloride concentrations. CFTR is a regulator of epithelial
Na1 channels (49). It is therefore possible that CFTR can
regulate the protein configuration or the channel permeability
of E-type ATPases as well. As mentioned before, E-type AT-
Pases share a molecular configuration related to epithelial Na1
channels; they have a large extracellular loop and only two
transmembrane domains. Possibly, CFTR can interact with
E-type ATPases triggering ATP release when activated by
cAMP. However, our results do not rule out the third possibility
mentioned above, in which granules containing a high concen-
tration of E-ATPase are incorporated abruptly by exocytosis to
the plasma membrane under the control of CFTR.
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